These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29540770)

  • 41. Interleukin-33: Its Emerging Role in Allergic Diseases.
    Ding W; Zou GL; Zhang W; Lai XN; Chen HW; Xiong LX
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29987222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
    Chen WY; Tsai TH; Yang JL; Li LC
    Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beyond IgE: Alternative Mast Cell Activation Across Different Disease States.
    Lyons DO; Pullen NA
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62.
    Ball DH; Al-Riyami L; Harnett W; Harnett MM
    Sci Rep; 2018 Mar; 8(1):4497. PubMed ID: 29540770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
    Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
    Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell response.
    Kawauchi T; Ishimaru K; Nakamura Y; Nakano N; Hara M; Ogawa H; Okumura K; Shibata S; Nakao A
    Allergol Int; 2017 Jul; 66(3):472-478. PubMed ID: 28259547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ATP/IL-33-triggered hyperactivation of mast cells results in an amplified production of pro-inflammatory cytokines and eicosanoids.
    Jordan PM; Andreas N; Groth M; Wegner P; Weber F; Jäger U; Küchler C; Werz O; Serfling E; Kamradt T; Dudeck A; Drube S
    Immunology; 2021 Nov; 164(3):541-554. PubMed ID: 34142370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of individual protein kinase C isoforms in mouse mast cell function and their targeting by the immunomodulatory parasitic worm product, ES-62.
    Bell KS; Al-Riyami L; Lumb FE; Britton GJ; Poole AW; Williams CM; Braun U; Leitges M; Harnett MM; Harnett W
    Immunol Lett; 2015 Nov; 168(1):31-40. PubMed ID: 26343793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pollen/TLR4 Innate Immunity Signaling Initiates IL-33/ST2/Th2 Pathways in Allergic Inflammation.
    Li J; Zhang L; Chen X; Chen D; Hua X; Bian F; Deng R; Lu F; Li Z; Pflugfelder SC; Li DQ
    Sci Rep; 2016 Oct; 6():36150. PubMed ID: 27796360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
    Cayrol C; Girard JP
    Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mast Cells as Drivers of Disease and Therapeutic Targets.
    Siebenhaar F; Redegeld FA; Bischoff SC; Gibbs BF; Maurer M
    Trends Immunol; 2018 Feb; 39(2):151-162. PubMed ID: 29196147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New roles and controls of mast cells.
    Espinosa E; Valitutti S
    Curr Opin Immunol; 2018 Feb; 50():39-47. PubMed ID: 29144996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.
    Gao W; Xiong Y; Li Q; Yang H
    Front Physiol; 2017; 8():508. PubMed ID: 28769820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innate and adaptive type 2 immunity in lung allergic inflammation.
    Kubo M
    Immunol Rev; 2017 Jul; 278(1):162-172. PubMed ID: 28658559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can Parasitic Worms Cure the Modern World's Ills?
    Harnett MM; Harnett W
    Trends Parasitol; 2017 Sep; 33(9):694-705. PubMed ID: 28606411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipopolysaccharide/TLR4 Stimulates IL-13 Production through a MyD88-BLT2-Linked Cascade in Mast Cells, Potentially Contributing to the Allergic Response.
    Lee AJ; Ro M; Cho KJ; Kim JH
    J Immunol; 2017 Jul; 199(2):409-417. PubMed ID: 28600286
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.